Literature DB >> 16545532

Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen.

Sadanobu Ogawa1, Takashi Kumada, Hidenori Toyoda, Hideo Ichikawa, Toshiaki Kawachi, Katsuhiko Otobe, Toshio Hibi, Kenji Takeshima, Seiki Kiriyama, Yasuhiro Sone, Makoto Tanikawa, Yasuhiro Hisanaga, Akihiro Yamaguchi, Masatoshi Isogai, Yuji Kaneoka, Junji Washizu.   

Abstract

Features of hepatocellular carcinoma (HCC) observed by contrast-enhanced ultrasonography (CEUS) were compared to pathological features of corresponding resected HCC specimens, to evaluate the ability of CEUS to depict the pathological features of HCC. We investigated 50 HCC nodules that were treated by surgical resection. All nodules had been examined by CEUS with intravenous contrast agent (Levovist) before surgery. CEUS findings were divided into three phases for evaluation and classification of enhancement patterns: two vascular phases (arterial phase and portal venous phase) and the delayed phase. Pathological examination focused on differentiation and on the presence or absence of a tumor capsule, intratumoral septum, and intratumoral necrosis. All 21 nodules that showed a linear or annular vessel around the tumor margin in the arterial phase had capsular formation. Of the 27 nodules that showed heterogeneous perfusion in the portal venous phase, 21 (77.8%) had an intratumoral septum and 23 (85.2%) showed intratumoral necrosis. All nodules that were depicted as a defect with an unclear margin in the delayed phase were well-differentiated HCCs, whereas all nodules that were depicted as a defect with a clear margin were moderately or poorly differentiated HCCs. From our observations, the arterial, portal venous, and delayed phases of CEUS could reflect different pathological aspects of HCC. Some pathological characteristics of HCC might be evaluated preoperatively and non-invasively, by means of combined analysis of three phases of CEUS findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545532     DOI: 10.1016/j.ejrad.2006.02.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.

Authors:  Xiao-Yun Zhang; Yan Luo; Tian-Fu Wen; Li Jiang; Chuan Li; Xiao-Fei Zhong; Jing-Yi Zhang; Wen-Wu Ling; Lu-Nan Yan; Yong Zeng; Hong Wu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Parametric imaging using contrast-enhanced ultrasound with Sonazoid for hepatocellular carcinoma.

Authors:  Manabu Watanabe; Kazue Shiozawa; Masayoshi Takahashi; Noritaka Wakui; Yuichiro Otsuka; Hironori Kaneko; Kayoko Tanikawa; Kazutoshi Shibuya; Naohisa Kamiyama; Yasukiyo Sumino
Journal:  J Med Ultrason (2001)       Date:  2010-01-05       Impact factor: 1.314

3.  Contrast-enhanced US of ampullary carcinoma: correlations with pathological findings.

Authors:  Nobuyuki Kiura; Shozo Okamura; Fumihiro Urano; Kazuhiro Hiramatsu; Matsuyoshi Maeda; Takuya Ishikawa; Hidemi Goto; Yoshiki Hirooka
Journal:  J Med Ultrason (2001)       Date:  2012-02-21       Impact factor: 1.314

4.  Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma.

Authors:  Keh M Ng; Tristan D Yan; Deborah Black; Francis C K Chu; David L Morris
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

5.  Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study.

Authors:  E M Jung; D A Clevert; A G Schreyer; S Schmitt; J Rennert; R Kubale; S Feuerbach; F Jung
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

6.  Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.

Authors:  Li-Da Chen; Si-Min Ruan; Jin-Yu Liang; Zheng Yang; Shun-Li Shen; Yang Huang; Wei Li; Zhu Wang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Wei Wang
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

7.  Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case report.

Authors:  Noritaka Wakui; Mitsuru Fujita; Yoshiya Yamauchi; Yuki Takeda; Nobuo Ueki; Takafumi Otsuka; Nobuyuki Oba; Shuta Nishinakagawa; Toshiko Takezoe; Junko Hiroyoshi; Yoshiharu Kono; Seiichiro Katahira; Masami Minagawa; Yasushi Takeda; Saori Shiono; Tatsuya Kojima
Journal:  Exp Ther Med       Date:  2013-04-30       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.